(Q34291962)

1 August 2017

1 reference

title

High-grade prostatic intraepithelial neoplasia. (English)

1 reference

high-grade prostatic intraepithelial neoplasia

1 August 2017

0 references

1

David G Bostwick

1 reference

1 August 2017

Junqi Qian

2

1 reference

1 August 2017

1 March 2004

1 reference

1 August 2017

1 reference

1 August 2017

17

1 reference

1 August 2017

3

1 reference

1 August 2017

360-379

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800053

1 August 2017

0 references

cites work

Molecular biology of prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Clinical evolution of prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Evolution of isolated high-grade prostate intraepithelial neoplasia in a Mediterranean patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia: a potential precursor lesion of prostatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intra-epithelial neoplasia and early invasion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

21 January 2018

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Selective estrogen receptor modulators for the chemoprevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostate cancer screening: role of the digital rectal examination and prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia in surgical resections: relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Significance of prosttic intraepithelial neoplasia on prostate needle biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Architectural patterns of high-grade prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Unusual histologic types of high-grade prostatic intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Does prostatic ductal adenocarcinoma exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Subtle changes in benign tissue adjacent to prostate neoplasia detected with a Bayesian belief network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Cytokeratin 34 beta E-12 immunoreactivity in benign prostatic acini. Quantitation, pattern assessment, and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

The proliferative function of basal cells in the normal and hyperplastic human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Telomerase activity modulation in the prevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Expression of androgen receptor and growth factors in premalignant lesions of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Estrogen receptor expression in prostate cancer and premalignant prostatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia: animal models 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

High-grade prostatic intraepithelial neoplasia in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Overview of benign prostatic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

The significance of prostatic intra-epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Prostatic intraepithelial neoplasia: the preinvasive stage of prostate cancer. Overview of the prostate committee report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

High-grade prostatic intraepithelial neoplasia: additional links to a potentially more aggressive prostate cancer?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Origins of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Epidemiology of high grade prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Working standards in prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Precursors of prostatic cancer: progression, regression and chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Age and racial distribution of prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Incidence of prostatic intra-epithelial neoplasia in Osaka, Japan

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Precursor lesions for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Apoptosis in prostatic adenocarcinoma following complete androgen ablation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Apoptotic bodies in prostatic intraepithelial neoplasia and prostatic adenocarcinoma following total androgen ablation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate: immunohistochemical and ultrastructural studies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Diagnosis of Cowper's glands on prostate needle biopsy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Atypical basal cell hyperplasia of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Absence of S-100 protein in prostatic glands

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

RER(+) phenotype in prostate intra-epithelial neoplasia associated with human prostate-carcinoma development

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Genetic pattern of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Ratio of free to total prostate-specific antigen in patients with prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Persistence of high-grade prostatic intra-epithelial neoplasia under combined androgen blockade therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Follow-up of prostatic intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800053

7 January 2021

10.1038/MODPATHOL.3800053

Identifiers

DOI

1 reference

PubMed ID

14739906

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

14739906